David Crawford, MD
Orthopaedic Surgery · New Albany, OHNPI 1073711982
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $192,560 of the $233,938 with a category attached, or 82.3%. Medacta USA, Inc. accounts for 89.8% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $63,318, more than ten times the $3,220 reported in 2019. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $708.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$210K
- Medical Device Business Services, Inc.$11K
- Depuy Synthes Products, Inc.$3K
- Stryker$3K
- Exactech, Inc.$2K
- Zimmer Biomet$1K
- plus $5K from 15 others
Across 12 payments — averaging $16,464 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$108K
- Medacta USA, Inc.$89K
What the payments were for
- Consulting fees$192,56082%
- Travel & lodging$27,17312%
- Food & beverage$12,0505%
- Education$2,0401%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 238 | $210,039 |
| Medical Device Business Services, Inc. | 6 | $10,598 |
| Depuy Synthes Products, Inc. | 6 | $2,873 |
| Stryker | 26 | $2,688 |
| Exactech, Inc. | 8 | $1,842 |
| Zimmer Biomet | 9 | $1,278 |
| CDC Medical LLC | 1 | $1,200 |
| Smith+Nephew | 2 | $810 |
| Bsn Medical Inc | 1 | $750 |
| Davol Inc. | 9 | $515 |
| Total Joint Orthopedics, Inc. | 5 | $255 |
| Si-bone, Inc. | 5 | $203 |
| Think Surgical, Inc. | 2 | $153 |
| Orthofix Medical, Inc. | 1 | $140 |
| Engage Uni, LLC | 1 | $114 |
| Johnson & Johnson | 4 | $113 |
| Heraeus Medical, LLC. | 1 | $111 |
| Globus Medical | 1 | $107 |
| Abbott | 1 | $97 |
| DJO, LLC | 2 | $31 |
| KCI USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$51,922
- GMK Sphere Revision System$35,069
- AMISTEM$26,721
- QUADRA$19,823
- MOTO Partial Knee System$14,696
- MOTO UNI$14,272
- ACTIS$7,550
- MYKNEE$7,465
- SPHERIKA$5,250
- AMIStem H Femoral Stems$2,485
- Quadra C Femoral Stems$2,450
- MAKO$1,771
- ALTEON$1,633
- Moto Sphere$918
- Velys$900
- Oxford$840
- BIRMINGHAM HIP$810
- PRIMARY SHOULDER$538
- Mfinity Cup$501
- Shoulder System$230
How this compares
$233,938 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 90 | $6,633 |
| XareltoRivaroxaban | 24 | $6,079 |
| Ondansetron Hcl | 134 | $457 |
| Meloxicam | 35 | $138 |
| Cephalexin | 123 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $113 | $6,07924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Other orthopaedic surgery in New Albany
- Michael CannoneNew Albany$116K
- Alexander AtheyNew Albany$93K
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.